Shingles Vaccine Global Market Report 2025

Description

Shingles vaccine is a preventive immunization designed to protect against shingles (herpes zoster), a painful skin rash caused by the reactivation of the varicella-zoster virus. It stimulates the immune system to recognize and combat the virus, reducing the risk of developing shingles and its associated complications.

The primary types of shingles vaccines include live attenuated vaccines, recombinant vaccines, and subunit vaccines. Live attenuated vaccines use a weakened form of the virus that can replicate without causing disease, eliciting a strong and lasting immune response. Key product types include Shingrix, Zostavax, and Skyzoster, primarily administered to individuals aged 50-59 years, 60-69 years, and 70 years and above. These vaccines are distributed through hospital pharmacies, online pharmacies, and retail pharmacies, serving end users such as hospitals, clinics, and pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The shingles vaccine market research report is one of a series of new reports from The Business Research Company that provides shingles vaccine market statistics, including shingles vaccine industry global market size, regional shares, competitors with a shingles vaccine market share, detailed shingles vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the shingles vaccine industry, This shingles vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The shingles vaccine market size has grown rapidly in recent years. It will grow from $4.82 billion in 2024 to $5.55 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth observed during the historic period can be attributed to the increasing elderly population, rising awareness of vaccine benefits, expansion of healthcare infrastructure and immunization programs, higher incidence of immunocompromised conditions, and growing adoption of newer, more effective vaccines.

The shingles vaccine market size is expected to see rapid growth in the next few years. It will grow to $9.58 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to expanding government reimbursement and favorable pricing policies, increasing physician recommendation rates, rising public health focus on adult vaccination, growing investment in research, development, and product diversification, and improvements in global supply chains and cold-chain capacity. Key trends during this period include advancements in recombinant vaccine technology, innovations in adjuvant systems, integration of shingles vaccination into adult immunization schedules, adoption of digital health platforms for vaccine tracking, and improvements in vaccine formulations.

The growing number of vaccination programs is driving the expansion of the shingles vaccine market. Organized public health initiatives that systematically deliver vaccines increase awareness, accessibility, and adoption, particularly among older adults and high-risk populations. These programs help reduce the incidence of shingles and its complications by promoting timely and widespread immunization, thereby improving overall community health. For example, in July 2025, the World Health Organization reported that global coverage for the first dose of the HPV vaccine in girls rose from 27% in 2023 to 31% in 2024, reflecting increased engagement in preventive vaccination initiatives.

Key players in the shingles vaccine market are focusing on innovative formulations to enhance protection. Recombinant adjuvanted vaccines, for instance, combine lab-produced viral proteins with adjuvants to boost immune response and provide long-lasting protection. In April 2023, GlaxoSmithKline Pharmaceuticals Ltd. launched Shingrix, a non-live, recombinant adjuvanted subunit vaccine administered in two doses for adults aged 50 and above. Shingrix offers over 90% protection against shingles, with immunity lasting at least 10 years, even in older or immunocompromised individuals.

In January 2022, Pfizer Inc. partnered with BioNTech SE to develop an mRNA shingles vaccine. This collaboration aims to leverage mRNA technology to elicit a robust and durable immune response against the varicella-zoster virus, providing a highly effective preventive solution for adults at risk of shingles.

Major players in the shingles vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., GSK plc, Daiichi Sankyo Company Limited, Moderna Inc., Novavax Inc., Biological E. Limited., Serum Institute of India Pvt. Ltd., Dynavax Technologies Corporation, SK Bioscience Co. Ltd., CanSino Biologics Inc., Vaxart Inc., EuBiologics Co. Ltd., BCHT Biotech Co. Ltd., Green Cross Corp, Jiangsu Recbio Technology Co. Ltd., Curevo Inc., Inovio Pharmaceuticals Inc., POP Biotechnologies Inc.

North America was the largest region in the shingles vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in shingles vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the shingles vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The shingles vaccine market consists of sales of vaccine kits, cold chain storage equipment, pre-filled syringes, vaccine delivery devices, and temperature monitoring systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Shingles Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on shingles vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for shingles vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The shingles vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Vaccine Type: Live Attenuated Vaccine; Recombinant Vaccine; Subunit Vaccine
2) By Product: Shingrix; Zostavax; Skyzoster
3) By Age Group: 50-59 Years; 60-69 Years; 70 Years And Above
4) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
5) By End User: Hospitals; Clinics; Pharmacies
Subsegments:
1) By Live Attenuated Vaccine: Virus Strain A; Virus Strain B; Virus Strain C
2) By Recombinant Vaccine: Recombinant Protein Vaccine; Recombinant Vector Vaccine; Recombinant Deoxyribonucleic Acid Vaccine
3) By Subunit Vaccine: Protein Subunit Vaccine; Polysaccharide Subunit Vaccine; Conjugate Subunit Vaccine
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; GSK plc; Daiichi Sankyo Company Limited; Moderna Inc.; Novavax Inc.; Biological E. Limited.; Serum Institute of India Pvt. Ltd.; Dynavax Technologies Corporation; SK Bioscience Co. Ltd.; CanSino Biologics Inc.; Vaxart Inc.; EuBiologics Co. Ltd.; BCHT Biotech Co. Ltd.; Green Cross Corp; Jiangsu Recbio Technology Co. Ltd.; Curevo Inc.; Inovio Pharmaceuticals Inc.; POP Biotechnologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37884

1. Executive Summary

2. Shingles Vaccine Market Characteristics

3. Shingles Vaccine Market Trends And Strategies

4. Shingles Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Shingles Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Shingles Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Shingles Vaccine Market Growth Rate Analysis
5.4. Global Shingles Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Shingles Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Shingles Vaccine Total Addressable Market (TAM)

6. Shingles Vaccine Market Segmentation

6.1. Global Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Vaccine
Recombinant Vaccine
Subunit Vaccine
6.2. Global Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Shingrix
Zostavax
Skyzoster
6.3. Global Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
50-59 Years
60-69 Years
70 Years And Above
6.4. Global Shingles Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
6.5. Global Shingles Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Pharmacies
6.6. Global Shingles Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Virus Strain A
Virus Strain B
Virus Strain C
6.7. Global Shingles Vaccine Market, Sub-Segmentation Of Recombinant Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Protein Vaccine
Recombinant Vector Vaccine
Recombinant Deoxyribonucleic Acid Vaccine
6.8. Global Shingles Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Subunit Vaccine
Polysaccharide Subunit Vaccine
Conjugate Subunit Vaccine

7. Shingles Vaccine Market Regional And Country Analysis

7.1. Global Shingles Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Shingles Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Shingles Vaccine Market

8.1. Asia-Pacific Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Shingles Vaccine Market

9.1. China Shingles Vaccine Market Overview
9.2. China Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Shingles Vaccine Market

10.1. India Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Shingles Vaccine Market

11.1. Japan Shingles Vaccine Market Overview
11.2. Japan Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Shingles Vaccine Market

12.1. Australia Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Shingles Vaccine Market

13.1. Indonesia Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Shingles Vaccine Market

14.1. South Korea Shingles Vaccine Market Overview
14.2. South Korea Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Shingles Vaccine Market

15.1. Western Europe Shingles Vaccine Market Overview
15.2. Western Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Shingles Vaccine Market

16.1. UK Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Shingles Vaccine Market

17.1. Germany Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Shingles Vaccine Market

18.1. France Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Shingles Vaccine Market

19.1. Italy Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Shingles Vaccine Market

20.1. Spain Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Shingles Vaccine Market

21.1. Eastern Europe Shingles Vaccine Market Overview
21.2. Eastern Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Shingles Vaccine Market

22.1. Russia Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Shingles Vaccine Market

23.1. North America Shingles Vaccine Market Overview
23.2. North America Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Shingles Vaccine Market

24.1. USA Shingles Vaccine Market Overview
24.2. USA Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Shingles Vaccine Market

25.1. Canada Shingles Vaccine Market Overview
25.2. Canada Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Shingles Vaccine Market

26.1. South America Shingles Vaccine Market Overview
26.2. South America Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Shingles Vaccine Market

27.1. Brazil Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Shingles Vaccine Market

28.1. Middle East Shingles Vaccine Market Overview
28.2. Middle East Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Shingles Vaccine Market

29.1. Africa Shingles Vaccine Market Overview
29.2. Africa Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Shingles Vaccine Market Competitive Landscape And Company Profiles

30.1. Shingles Vaccine Market Competitive Landscape
30.2. Shingles Vaccine Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GSK plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Shingles Vaccine Market Other Major And Innovative Companies

31.1. Moderna Inc.
31.2. Novavax Inc.
31.3. Biological E. Limited.
31.4. Serum Institute of India Pvt. Ltd.
31.5. Dynavax Technologies Corporation
31.6. SK Bioscience Co. Ltd.
31.7. CanSino Biologics Inc.
31.8. Vaxart Inc.
31.9. EuBiologics Co. Ltd.
31.10. BCHT Biotech Co. Ltd.
31.11. Green Cross Corp
31.12. Jiangsu Recbio Technology Co. Ltd.
31.13. Curevo Inc.
31.14. Inovio Pharmaceuticals Inc.
31.15. POP Biotechnologies Inc.

32. Global Shingles Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Shingles Vaccine Market

34. Recent Developments In The Shingles Vaccine Market

35. Shingles Vaccine Market High Potential Countries, Segments and Strategies

35.1 Shingles Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Shingles Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Shingles Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer